Research Into ME/CFS Pathology Points to Possible Treatments

Medscape Medical News > Conference News > IACFS/ME 2025 Research Into ME/CFS Pathology Points to Possible Treatments Miriam E. Tucker November 07, 2025 New possibilities for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are emerging as research continues to untangle the complex, multisystem pathophysiology of the two overlapping diseases. At International […]

Research Into ME/CFS Pathology Points to Possible Treatments

Research Into ME/CFS Pathology Points to Possible Treatments Miriam E. Tucker November 07, 2025 New possibilities for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are emerging as research continues to untangle the complex, multisystem pathophysiology of the two overlapping diseases. At International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (IACFS/ME) 2025, […]

Potential pathophysiological role of the ion channel TRPM3 in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the therapeutic effect of low-dose naltrexone

Journal of Translational Medicine 2024 Jul 5;22(1):630. Matthias Löhn & Klaus Josef Wirth Abstract Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating disease with a broad overlap of symptomatology with Post-COVID Syndrome (PCS). Despite the severity of symptoms and various neurological, cardiovascular, microvascular, and skeletal muscular findings, no biomarkers have been identified. The Transient receptor […]

Andrea takes LDN to manage POTS, MCAS, long COVID, Fibromyalgia, and Myalgic Encephalomyelitis

 Linda Elsegood interviewing Andrea, a patient from the United States who has been taking low dose naltrexone (LDN) to manage her health concerns. Andrea has been struggling with various conditions, including postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), long Covid, fibromyalgia, and myalgic encephalomyelitis. Throughout the interview, Andrea delves into the details […]

Potential pathophysiological role of the ion channel TRPM3 in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the therapeutic effect of low-dose naltrexone

Review  Open access  Published: 05 July 2024 Volume 22, article number 630, (2024) Matthias Löhn & Klaus Josef Wirth Abstract Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating disease with a broad overlap of symptomatology with Post-COVID Syndrome (PCS). Despite the severity of symptoms and various neurological, cardiovascular, microvascular, and skeletal muscular findings, no biomarkers have been […]

Potential pathophysiological role of the ion channel TRPM3 in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the therapeutic effect of low-dose naltrexone

Potential pathophysiological role of the ion channel TRPM3 in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the therapeutic effect of low-dose naltrexone 05 July 2024, Volume 22, article number 630, (2024) Matthias Löhn and Klaus Josef Wirth Journal of Translational Medicine  Abstract Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating disease with a broad overlap of symptomatology […]

Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia

Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia Hiten Naik et al. Online issue publication May 13, 2024 Abstract Introduction A significant proportion of individuals suffering from post COVID-19 condition (PCC, also known as long COVID) can present with persistent, disabling fatigue similar to myalgic encephalomyelitis/chronic […]

Exciting breakthrough offers hope for Long COVID patients

Exciting breakthrough offers hope for Long COVID patients Published May 7, 2024 Author Emma O’Connor – Griffith University https://news.griffith.edu.au/2024/05/07/exciting-breakthrough-offers-hope-for-long-covid-patients/ Researchers from Griffith University’s National Centre for Neuroimmunology and Emerging Diseases (NCNED) have made a groundbreaking discovery that could bring relief to those struggling with Long COVID. In a world-first finding, they’ve identified a way to […]

Addiction Medication Offers New Hope for Long COVID Patients

Addiction Medication Offers New Hope for Long COVID Patients Featured in Neurology Neuroscience·May 7, 2024 https://neurosciencenews.com/naltrexone-long-covid-26048/ Summary: Researchers identified a potential treatment for long COVID by restoring the function of ion channels in immune cells using low-dose Naltrexone. This discovery, detailed in Frontiers in Immunology, mirrors earlier findings with chronic fatigue syndrome (ME/CFS) patients, suggesting […]